ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1188.xml EGFR-Mutant Non–Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline EGFR T790M Testing2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1188.pdf2026-04-18 EGFR-Mutant Non–Small Cell Lung Cancer in the Era of Precision Medicine: Importance of Germline EGFR T790M Testinghttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1193.xmlNCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1193.pdf2026-04-18NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1180.xmlImplementation Framework for NCCN Guidelines2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1180.pdf2026-04-18Implementation Framework for NCCN Guidelineshttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1186.xmlTo the Editor: Predictive Markers and Precision Medicine2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1186.pdf2026-04-18To the Editor: Predictive Markers and Precision Medicinehttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-pxl.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-pxl.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-pxxxiii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-pxxxiii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1179.xmlServing “a la CAR-T”: Value-Based Pricing and Gene Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1179.pdf2026-04-18Serving “a la CAR-T”: Value-Based Pricing and Gene Therapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1208.xmlThe Senior Toronto Oncology Panel (STOP) Study: Research Participation for Older Adults With Cancer and Caregivers2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1208.pdf2026-04-18The Senior Toronto Oncology Panel (STOP) Study: Research Participation for Older Adults With Cancer and Caregivershttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1240.xmlBladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1240.pdf2026-04-18Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1224.xmlDistress and Financial Distress in Adults With Cancer: An Age-Based Analysis2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1224.pdf2026-04-18Distress and Financial Distress in Adults With Cancer: An Age-Based Analysishttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1216.xmlPathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1216.pdf2026-04-18Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1234.xmlA Population-Based Assessment of Emergency Department Observation Status for Older Adults With Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1234.pdf2026-04-18A Population-Based Assessment of Emergency Department Observation Status for Older Adults With Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1268.xmlClinical Significance of Histologic Variants of Bladder Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1268.pdf2026-04-18Clinical Significance of Histologic Variants of Bladder Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1277.xmlUrothelial Carcinoma of the Bladder and the Rise of Immunotherapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1277.pdf2026-04-18Urothelial Carcinoma of the Bladder and the Rise of Immunotherapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1285.xmlAdmission or Observation? Population Health Is Here2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/10/article-p1285.pdf2026-04-18Admission or Observation? Population Health Is Here